September 4, 2017:
To coincide with National Asthma Week (1-7 September 2017) and the start of Spring, the new ASCIA Allergic Rhinitis Clinical Update for health professionals has been released. This document complements ASCIA allergic rhinitis e-training courses for health professionals and is available open access and free of charge on the ASCIA website:
This document includes important information asthma, thunderstorm asthma and a link to the recently updated ASCIA Treatment Plan for Allergic Rhinitis:
ASCIA allergic rhinitis e-training courses for health professionals are available free of charge on the ASCIA website:
Allergic rhinitis (hay fever) and asthma are often referred to as “United airway disease”. This is due to them being upper and lower respiratory tract manifestations of the same inflammatory process. For example, inhalation of aeroallergens through the nose may contribute to inflammation in lung. Allergic rhinitis is a risk factor for subsequent asthma development and effective treatment of allergic rhinitis improves asthma management.
Patients with either asthma or allergic rhinitis should therefore be assessed for coexistent disease, particularly because:
- 50-80% of patients with asthma have allergic rhinitis.
- 20-30% of patients with allergic rhinitis have asthma.